» Articles » PMID: 15950004

Molecular Genetics of Attention-deficit/hyperactivity Disorder

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2005 Jun 14
PMID 15950004
Citations 728
Authors
Affiliations
Soon will be listed here.
Abstract

Results of behavioral genetic and molecular genetic studies have converged to suggest that both genetic and nongenetic factors contribute to the development of attention-deficit/hyperactivity disorder (ADHD). We review this literature, with a particular emphasis on molecular genetic studies. Family, twin, and adoption studies provide compelling evidence that genes play a strong role in mediating susceptibility to ADHD. This fact is most clearly seen in the 20 extant twin studies, which estimate the heritability of ADHD to be .76. Molecular genetic studies suggest that the genetic architecture of ADHD is complex. The few genome-wide scans conducted thus far are not conclusive. In contrast, the many candidate gene studies of ADHD have produced substantial evidence implicating several genes in the etiology of the disorder. For the eight genes for which the same variant has been studied in three or more case-control or family-based studies, seven show statistically significant evidence of association with ADHD on the basis of the pooled odds ratio across studies: DRD4, DRD5, DAT, DBH, 5-HTT, HTR1B, and SNAP-25.

Citing Articles

The association between maternal tobacco smoking during pregnancy and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring: A systematic review and meta-analysis.

Mohammadian M, Khachatryan L, Vadiyan F, Maleki M, Fatahian F, Mohammadian-Hafshejani A PLoS One. 2025; 20(2):e0317112.

PMID: 39919144 PMC: 11805386. DOI: 10.1371/journal.pone.0317112.


Evaluation of procalcitonin and C-reactive protein levels in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Adiguzel Akman O, Esnafoglu E Int J Dev Disabil. 2025; 71(1):159-167.

PMID: 39882415 PMC: 11774147. DOI: 10.1080/20473869.2023.2213923.


Beyond the Brain: Attention Deficit/Hyperactivity Disorder and the Gut-Brain Axis.

Gandhi D, Pande D, Harikrishna A, Advilkar A, Basavan I, Ansari R Cureus. 2025; 16(12):e76291.

PMID: 39850178 PMC: 11754923. DOI: 10.7759/cureus.76291.


Magnetic resonance imaging evaluation and nuclear receptor binding SET domain protein 1 mutation in the Sotos syndrome with attention-deficit/hyperactivity disorder.

Zhu W World J Clin Cases. 2025; 13(2):98319.

PMID: 39823103 PMC: 11577501. DOI: 10.12998/wjcc.v13.i2.98319.


Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders.

Dalvi S, Bhatt L Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39738834 DOI: 10.1007/s00210-024-03757-6.